US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.9300
- +0.0500+2.66%
Close Nov 25 16:00 ET
- 1.9400
- +0.0100+0.52%
Pre 08:32 ET
421.09MMarket Cap-8772P/E (TTM)
1.9700High1.8800Low2.55MVolume1.9000Open1.8800Pre Close4.94MTurnover1.29%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-8.35P/B382.67MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM4.79%Amplitude0.2410Historical Low1.9330Avg Price1Lot Size
Akebia Therapeutics Key Stats
EPS
According to the latest financial report of Akebia Therapeutics, the latest earnings per share (TTM) for the company is -0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Akebia Therapeutics's free cash flow? The latest report shows it as -6.70M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Akebia Therapeutics shows that the company's current ratio is 1.52, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Akebia Therapeutics, the quick ratio is 1.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Akebia Therapeutics? The latest ROE figure is -63.63%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Akebia Therapeutics, the total asset return on investment (ROA) is -9.38%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Akebia Therapeutics's latest financial report to see how their gross margin is doing - currently at 62.16%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Akebia Therapeutics, the net profit margin is -53.54%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data